Gooderham , M. (2021) “The Era of IL-23: Introduction of Tildrakizumab”, Canadian Dermatology Today. Toronto, Canada, 2(s03), p. 2. Available at: https://canadiandermatologytoday.com/article/view/2-s03-gooderham (Accessed: 21 November 2024).